Sulindac sulfide inhibits Ras signaling

Oncogene

Volumn 17, Issue 14, 1998, Pages 1769-1776

  Herrmann, Christian ^a   Block, Christoph ^a   Geisen, Christoph ^b   Haas, Kirsten ^b   Weber, Christoph ^c   Winde, Günther ^d   Möröy, Tarik ^b   Müller, Oliver ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Non steroidal anti inflammatory drugs; p21ras; Sulindac

Indexed keywords

CYCLIN DEPENDENT KINASE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; SULINDAC SULFIDE;

ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0032497698     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202085     Document Type: Article

References (44)

1. Ahmadian MR, Hoffmann U, Goody RS and Wittinghofer A. (1997). Biochemistry, 36, 4535-4541.
2. Block C, Janknecht R, Herrmann C, Nassar N and Wittinghofer A. (1996). Nature Struct. Biol., 3, 244-251.
3. Bollag G and McCormick F. (1991). Nature, 351, 576-579.
4. Bos JL. (1989). Cancer Res., 49, 4682-4689.
5. Chiu CH, McEntee MF and Whelan J. (1997). Cancer Res., 57, 4267-4273.
6. Cravchik A and Matus A. (1993). Gene, 137, 139-143.
7. Flory F, Weber CK, Chen P, Hoffmeyer A, Jassoy C and Rapp UR. (1998). J. Virol., 72, 2788-2794.
8. Giardiello FM. (1994). Cancer Metast. Rev., 13, 279-283.
9. Gideon P, John J, Frech M, Lautwein A, Clark R, Scheffler JE and Wittinghofer A. (1992). Mol. Cell. Biol., 12, 2050-2056.
10. Goldberg Y, Nassif I, Pittas A, Tsai LL, Dynlacht BD, Rigas B and Shiff SJ. (1996). Oncogene, 12, 893-901.
11. Golubic M, Tanaka K, Dobrowolski S, Wood D, Tsai M-H, Marshall M, Tamanoi F, Stacey DW. (1991). EMBO J., 10, 2897-2903.
12. Haas K, Johannes C, Greisen C, Schmidt T, Karsunky H, Blass-Kampmann S, Obe G and Möröy T. (1997a). Oncogene, 15, 2615-2623.
13. Haas K, Staller P, Geisen C, Bartek J, Eilers M and Möröy T. (1997b). Oncogene, 15, 179-192.
14. Han JW, McCormick F and Macara IG. (1991). Science, 252, 576-579.
15. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI and Rigas B. (1996). Biochem. Pharmacol., 52, 237-245.
16. Herrmann C, Horn G, Spaargaren M and Wittinghofer A. (1996). J. Biol. Chem., 271, 6794-6800.
17. Herrmann C, Martin GA and Wittinghofer A. (1995). J. Biol. Chem., 270, 2901-2905.
18. Janknecht R, Ernst WH, Pingoud V and Nordheim A. (1993). EMBO J., 12, 5097-5104.
19. Janknecht R. (1996). Mol. Cell. Biol., 16, 1550-1556.
20. Land H, Parada L and Weinberg RA. (1983). Nature, 304, 596-602.
21. Leevers SJ, Paterson HF and Marshall CL, (1994). Nature, 369, 411-414.
22. Lenzen C, Cool RH and Wittinghofer A. (1995). Meth. Enzym., 255, 95-98.
23. Lovec H, Sewing A, Lucibello FC, Müller R and Möröy T. (1994). Oncogene, 9, 323-326.
24. Luk GD. (1996). Schweiz. Med. Wochenschrift, 126, 801-812.
25. Mosmann T. (1983). J. Immun. Meth., 65, 55-63.
26. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F and Wittinghofer A. (1995). Nature, 375, 554-560.
27. Pasricha PJ, Pai R, Ravich WJ, Hendrix TR and Kalloo AN. (1995). Gastroenterology, 109, 994-998.
28. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA and Ewen ME. (1997). Nature, 386, 177-181.
29. Piazza GA, Alberts DS, Hixson U, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen W and Pamukcu R. (1997a). Cancer Res., 57, 2909-2915.
30. Piazza GA, Rahm AL, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R and Ahnen DJ. (1997b). Cancer Res., 57, 2452-2459.
31. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burl RW, Alberts DS and Pamukcu R. (1995). Cancer Res., 55, 3110-3116.
32. Qiao L, Kozoni V, Tsioulias GJ, Koutsos ML Hanif R, Shiff SJ and Rigas B. (1995). Biochim. Biophys. Acta, 1258, 215-223.
33. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V and Reddy BS. (1995). Cancer Res., 55, 1464-1472.
34. Seheffzek K, Ahmadian MR, Kabseh W, Wiesmüller L, Lautwein A, Schmitz F and Wittinghofer A. (1997). Science, 277, 333-338.
35. Schweins T, Geyer M, Kalbitzer HR, Wittingholer A and Warshel A. (1996). Biochemistry, 35, 14225-14231.
36. Shiff SJ, Qiao L, Tsai LL and Rigas B. (1995). J. Clin. Invest., 96, 491-503.
37. Stokoe D, MacDonald SG, Cadwallader K, Symons M and Hancock JF. (1994). Science, 264, 1463-1467.
38. Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R and Ahnen DJ. (1997). Cancer Res., 57, 267-271.
39. Tsai MH, Yu CL, Wie FW and Stacey DW. (1989). Science, 243, 522-526.
40. Tsujii M and DuBois RN. (1995). Cell, 83, 493-501.
41. Vane JR and Botting RM. (1996). Scandin. J. Rheumatol., 102, 9-21.
42. Winde G, Schmid KW, Schlegel W, Fischer R, Osswald H and Bunte H. (1995). Dis. Col. Rect., 38, 813-830.
43. Wixler V, Smola U, Schuler M and Rapp UR. (1996). FEBS Lett., 385, 131-137.
44. Wright JD, Boudinot FD and Ujhelyi MR. (1996). Clin. Pharmacokinet., 30, 445-462.